Почетна › Прекумерна телесна тежина › Јужна Каролина

Клинички испитувања за Прекумерна телесна тежина во Јужна Каролина

35 студии за Прекумерна телесна тежина бараат учесници на локации во Јужна Каролина.

Градови во Јужна Каролина

Официјален текст на студијата (англиски)

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Spartanburg Medical Research, Spartanburg

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Prisma Health-Ped Endo, Greenville
Coastal Carolina Research Ctr, North Charleston

Се регрутираФаза 3

Возраст од 8 до 18 · Сите полови · Ажурирано 30.9.2026 · NCT07253285

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Tribe Clinical Research, Greenville

Се регрутираФаза 2

Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Medical Uni of SC Charleston, Charleston
Coastal Carolina Research Ctr, North Charleston
Hillcrest Clinical Research, Simpsonville
и уште 1

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Medical University Of South Carolina, Charleston
Hillcrest Clinical Research, Simpsonville
Spartanburg Medical Research, Spartanburg

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Care Access - Mauldin, Mauldin

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Gastroenterology Associates - Patewood, Greenville

Се регрутираФаза 3

Возраст од 18 до 70 · Сите полови · Ажурирано 24.9.2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Coastal Pediatric Associates, Charleston
Medical University of South Carolina Children Hospital - PIN, Charleston

Се регрутираФаза 3

Возраст од 6 до 17 · Сите полови · Ажурирано 24.9.2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Associates - Patewood, Greenville

Се регрутираФаза 3

Возраст од 18 до 70 · Сите полови · Ажурирано 24.9.2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Accellacare - Mt Pleasant, Mt. Pleasant

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Trial Management Associates, Myrtle Beach

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Bogan Sleep Consultants, Columbia

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Accellacare Charleston, Mt. Pleasant

Се регрутираФаза 3

Возраст од 45 до 99 · Сите полови · Ажурирано 22.9.2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Tribe Clinical Research, LLC, Greenville
Accellacare - Mt Pleasant, Mt. Pleasant

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Tribe Clinical Research, LLC, Greenville

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 22.9.2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Bluffton
AURORA-1 Clinical Site, Clemson
AURORA-1 Clinical Site, Columbia
и уште 1

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Bluffton
AURORA-2 Clinical Site, Clemson
AURORA-2 Clinical Site, Columbia
и уште 1

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Coastal Carolina Research Center, North Charleston

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Trial Management Associates, Myrtle Beach

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Greer

Се регрутираФаза 3Добредојдени се здрави волонтери

Возраст од 18 до 79 · Сите полови · Ажурирано 11.9.2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Spartanburg Medical Research, Spartanburg

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07770841

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Bogan Sleep Consultants, LLC, Columbia

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Tribe Clinical Research, LLC, Greenville

Се регрутираФаза 2

Возраст од 18 до 75 · Сите полови · Ажурирано 8.9.2026 · NCT06143956

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Columbia Dermatology & Aesthetics, Columbia

Се регрутираФаза 4

Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT06857942

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Coastal Carolina Res Ctr, North Charleston

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Spartanburg

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Tribe Clinical Research LLC Dba Mountain View Clinical Research, Greenville

Се регрутираФаза 3

Возраст од 18 до 99 · Сите полови · Ажурирано 3.9.2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Mauldin

Се регрутираФаза 3

Возраст 18 и постари · Сите полови · Ажурирано 3.9.2026 · NCT07284875

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Greer

Се регрутираФаза 3

Возраст од 18 до 79 · Сите полови · Ажурирано 10.8.2026 · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Coastal Carolina Research Ctr, North Charleston

Се регрутираФаза 1

Возраст 18 и постари · Сите полови · Ажурирано 25.6.2026 · NCT07607587

A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.

Monroe Biomedical Research, North Charleston

Се регрутираФаза 2

Возраст од 18 до 60 · Сите полови · Ажурирано 22.6.2026 · NCT07570758

Efficacy of Center-based Childcare to Mitigate Unhealthy Weight Gain in Preschoolers From Low-income Households During the Summer

University of South Carolina, Columbia

Се регрутираДобредојдени се здрави волонтери

Возраст од 3 до 5 · Сите полови · Ажурирано 11.6.2026 · NCT07583459

Pistachio Snacking and Metabolic Flexibility

Public Health Research Center: Clinical Exercise Research Center, Columbia

Се регрутираДобредојдени се здрави волонтери

Возраст од 25 до 45 · Сите полови · Ажурирано 14.1.2026 · NCT07340125

Optimal Digital Weight Loss Treatment for Rural Individuals

University of South Carolina, Columbia

Се регрутираДобредојдени се здрави волонтери

Возраст 18 и постари · Сите полови · Ажурирано 23.12.2025 · NCT06105957

Fueling Strong Hearts for a Strong South Carolina

Pee Dee Research and Education Center, Florence

Се регрутира

Возраст од 45 до 80 · Сите полови · Ажурирано 26.8.2025 · NCT07140952

Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.